USA flag logo/image

An Official Website of the United States Government

Recombinant ISA Virus Vaccine

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
62049
Program Year/Program:
2004 / SBIR
Agency Tracking Number:
2003-00478
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Maine BioTek, Inc.
259 MAIN STREET Suite 208 WINTERPORT, ME 04496 0408
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2004
Title: Recombinant ISA Virus Vaccine
Agency: USDA
Contract: 2004-33610-14785
Award Amount: $296,000.00
 

Abstract:

Infectious salmon anemia (ISA) virus is an emerging pathogen of farmed Atlantic salmon (Salmo salar). The virus is among the fish pathogens listed in the Aquatic Animal Health Code of the Office International des Epizooties (OIE). As such, ISA is a notifiable disease and compulsory eradication policies are enforced worldwide. Control measures, such as an efficacious vaccine, would reduce the viral load in farm sites and could form an integral component of adaptive management strategies for the protection and recovery of endangered Atlantic salmon in Maine, stock enhancement and continued productive commercial and recreational fisheries. The goal of this project is to develop a safe, efficacious and cost effective recombinant vaccine using ISA virus antigens that we have identified as contributing to immunoprotection and to enhance the efficacy of the vaccine through optimization of the dose, formulation and antigen combination.

Principal Investigator:

Sharon Clouthier
2072234662
sclouthier@hotmail.com

Business Contact:

Sharon Clouthier
President
2072234662
sclouthier@hotmail.com
Small Business Information at Submission:

Maine BioTek, Inc.
P.O. Box 408, 259 Main Street Winterport, ME 04496

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No